Novel dual HIV maintenance therapy with nevirapine plus lamivudine retain viral suppression through 144 weeks-A proof-of-concept study - Publication - Authors - KSSG Research Database

Publication

Novel dual HIV maintenance therapy with nevirapine plus lamivudine retain viral suppression through 144 weeks-A proof-of-concept study

Journal Paper/Review - Sep 23, 2020

Kahlert Christian, Cipriani M, Vernazza Pietro

Kahlert, Christian

attending physician mbF
Division of Infectious Diseases, Infection Prevention and Travel Medicine · Dept. I

Cipriani, M

Vernazza, Pietro